BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10

• Press Releases

  Alebund Presents Phase 3 Trial Results of AP301 at the American Society of Nephrology (ASN) 2025 Congress

  November 10, 2025

   · 

  6 min read
• Press Releases

  Relmada Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 13, 2025

  November 10, 2025

   · 

  1 min read
• Press Releases

  GenVivo to Present Phase 1 Trial Results for GEN2, A Personalizing Systemic Cancer Immunotherapy, at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting

  November 10, 2025

   · 

  6 min read
• Press Releases

  Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 7, 2025

  November 10, 2025

   · 

  2 min read
• Press Releases

  ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)

  November 10, 2025

   · 

  17 min read
• Press Releases

  Muna Therapeutics Announces First Subjects Dosed in Phase 1 Trial of Novel Oral TREM2 Agonist for Early Alzheimer’s Disease

  November 10, 2025

   · 

  3 min read
• Press Releases

  Data Supporting the Potentially Differentiated Pharvaris Portfolio Presented at ACAAI 2025 Annual Scientific Meeting

  November 10, 2025

   · 

  12 min read
• Press Releases

  Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics

  November 10, 2025

   · 

  11 min read